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Aim. To evaluate the clinical results of embolisation of symptomatic, incompetent pelvic veins in women presenting with
perineal veins.
Patients and methods. Twenty-four women presenting with non-saphenous perineal varicose veins and who experi-
enced pelvic vein syndrome were treated. Symptoms was scored on a visual analogue scale assessing dyspareunia, pelvic
and lower limb pain. Lower limb varices were investigated by duplex ultrasonography. Pelvic veins were studied by
pelvic vein angiography with simultaneous embolisation of incompetent veins. Ovarian and internal iliac veins were
systematically embolised when incompetent. Follow-up assessment of symptoms and varices was carried out at 1, 2
and 3 years.
Results. All patients presented with perineal veins, 2 with sciatic vein incompetence and 2 with a perforator of the thigh or
buttock. Pelvic venous angiography was performed via right femoral access in 87% of the cases and confirmed the presence
of incompetent ovarian and internal iliac veins. The mean number of coils used per vein was 6 and all were successfully
embolised. No serious complications were encountered. The mean clinical improvement score was 80%, 77%, 80% and
76% at respectively 45 days, 1, 2 and 3-year follow-up.
Conclusion. In women of reproductive age, non-saphenous varicose veins associated with pelvic venous incompetence
(PVI) should undergo pelvic vein investigation. In this clinical series we achieved a satisfactory improvement in symptoms
after 3 years following treatment of incompetent pelvic veins.
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In women, clinical symptoms of pelvic vein incompe-
tence (PVI) have been recognised for years.1 They
were often considered an inevitable part of the
chronic pelvic pain that young multiparous women
had to suffer. The first surgical treatments were
achieved by transperitoneal ligation and division of
ovarian veins, but this is a very invasive treatment
and is no longer carried out. Modern radiological in-
vestigation of pelvic veins has made it possible better
to understand, pelvic vein anatomy and anastomoses
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the pathological role of PVI in clinical pelvic symp-
tomatology. Duplex ultrasound studies have shown
that varicose veins do not always originate from sa-
phenous systems,3,4 especially in the case of recurrent
varices.5,6 Varicose veins of the lower limb may de-
pend solely on pelvic vein incompetence. Evaluation
of pelvic symptoms may indicate the presence of a pel-
vic aetiology of varicose veins. In a previous study,7
a significant correlation between radiological PVI
and pelvic clinical symptoms has been demonstrated.
The aim of this series was to use evaluation of
symptoms in women of reproductive age to select
those where pelvic venous embolisation was indi-
cated amongst those presenting with non-saphenous
varices and to evaluate the outcome at three years.ved.
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Patients
Between 2000 and 2002 amongst 895 female patients as-
sessed in a phlebological practice, 24 non-menopausal
women were selected who presented with non-
saphenous varices of pelvic origin and clinical symp-
toms of PVI . The first criteria for selection was the
presenceofnon-saphenousvarices of pelvic origin: var-
icose veins at buttock level, perineal or vulval varicose
veins, or varicose veins situated at the popliteal fossa
fed byPVI via the sciatic nerve vein.Duplex ultrasound
examination was carried out in the standing position
(Hitachi Katana 5, 7.5 MHz transducer; Ecoscan, Les
Ulis, France). Patients who had previously undergone
varicose vein surgery were assessed to ensure that no
varicose veins originated from the previously treated
sapheno-femoral junction. The deep system was also
studied to excludepatientswith ‘nutcracker syndrome’
(mesoaortic compression of the left renal vein). Patients
whose varicose veins originated principally from
connections with the femoral vein were excluded.
The second selection criteria depended on the ex-
tent of symptoms of PVI. Among the various symp-
toms of PVI, as described by Taylor,1 (premenstrual
or menstrual pelvic pains, dyspareunia, vulval con-
gestion, dysuria, bladder irritability and urgency,
digestive disorders, medical history of vulval varicose
veins during deliveries, and haemorrhoids), only 3
particularly clear symptoms were chosen to be evalu-
ated. These were selected based on the findings of
a previous study,7 in which a significant correlation
between radiological PVI and these three symptoms
was demonstrated. Symptoms were assessed by 3
visual analogue scales (VAS) graduated from 0 to 10
(0 was no pain and 10 the maximum pain) completed
by the patient during consultations:
1. VAS for pelvic menstrual pain occurring specifi-
cally before or during menstruation (0-10),
2. VAS for pain on the varicose vein tracks occurring
specifically before or during menstruation (0-10),
3. VAS for dyspareunia occurring specifically during
or after intercourse (0-10).
The scores obtained were added to produce a global
symptom score ranging from 0 to 30. Patients with no
painor a score below6were excluded.Non-menopausal
women with a score above 6 were chosen for inclusion.
We did not assess the presence of incompetent pelvic
veins by transvaginal ultrasonography since this has
been found to be an unreliable technique.8 Before the
procedure, all patients gave informed written consentand were asked to return for clinical examination and
symptom assessment at 45 days, and at 1, 2 and 3 years
after the intervention. One day prior to the planned
varicose vein surgery, all patients underwent pelvic
venous angiography with embolisation of incompetent
pelvic veins.
Pelvic vein angiography and embolisation
Pelvic vein angiography was carried out via a femoral
vein canulation with a 4 or 5 French introducer under
local anaesthesia and neuroleptanalgesia. Percutane-
ous catheterisation of the venous segments was carried
out with a Sindewinder catheter (Cordis SA, Johnson&
Johnson Company, Issy les Moulineaux, France), and
a hydrophilic guide support (Te´rumo, Guyancourt,
France) with a flexible tip. The veins were selectively
catheterised in the following order: the left renal vein,
the left ovarian vein, the right ovarian vein, the left
internal iliac vein, the left external iliac vein, the right
internal iliac vein and the right external iliac vein.
Venous opacification was first carried out at
rest and then under pressure (Valsalva manoeuvre),
with a hydro-soluble, hypo-osmolar contrast com-
pound at a 270 mg/ml concentration (Visipaque 270,
Amersham-Health, Pantin, France), at a dose of 9 to
12 ml, at a 3 to 4 ml/sec flow rate.
Diagnostic and therapeutic procedures were car-
ried out simultaneously. Each ovarian or internal iliac
vein with significant reflux was embolised at the same
time as the selective catheterisation, and prior to in-
vestigation of the next part of the venous system.
The pathological reflux criteria that were taken into
account to carry out embolisation were:
- Voluminous ovarian varicocele (fed by ovarian
vein reflux, evident on injection of the left renal
vein).
- Varicose reflux toward the ipsi- or contro-lateral
proximal thigh.
- Reflux toward perineal and vulvar veins.
- Reflux toward the ipsi-lateral sciatic vein.
Embolisation was carried out with small metallic
coils (Cook, Bloomington, USA) with a 0.03800 calibre,
a length of 3 to 8 cm, and a diameter of 3 to 10 mm.
Coil size was selected according the calibre and the
morphology of the affected venous segment. In an
ovarian vein, coils were placed at the lower level of
the sacro-iliac joint and at the level of the L5 and L4
vertebrae, to adapt to possible upwardly situated col-
laterals, until complete occlusion and absence of
reflux were obtained under abdominal pressure. InEur J Vasc Endovasc Surg Vol 34, July 2007
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eterization was performed up to the origin of the
incompetent vein to embolise it. No glue, foam, or
sclerosing product was used.
Surgery
After pre-operative ultrasound marking of varices
(Esaote AU 530, 10 MHz transducer), phlebectomies
were carried out under loco-regional anaesthesia
with a femoral block. The number of phlebectomy in-
cisions, which corresponds to the extent of the varices,
was also noted. Post operative compression was
achieved by two superimposed class II French stock-
ings (2 20¼ 40 mm Hg) for two days and then by
one stocking for 2 weeks.
Clinical outcome
Outcome was assessed on clinical freedom varices and
symptoms of pelvic pain. Assessment was performed
by the same investigator, after one month to evaluate
symptoms during the following menstrual periods.
At one, two and three years, the same assessment was
repeated. During these consultations the same 3 VAS
was completed and the global symptom score was
calculated. Patients who were unable to come for a
consultation, were interviewed on the phone.
The clinical assessment of varices was divided into
4 categories:
Type 1 (Excellent result): Absence of varicose veins
(equivalent to class C0, C1 of the CEAP classification),
Type 2 (Good result): Presence of only very few new
varices, Type 3 (Poor results): Presence of new varices,
but fewer than previously, Type 4 (Bad results): Pres-
ence of the same amount of varicose veins as before
treatment.
Patients who were unable to attend for clinical
evaluation at the 3-year follow-up were asked to
answer a questionnaire constructed with the same
definitions as above.
Statistics
Scores were measured on 5 occasions: before emboli-
sation, at 45-days, 1, 2 and 3-year follow-up. A statis-
tical analysis was performed with SAS v8 software.
The score and time at follow-up assessed by analysis
of variance. Means were compared two by two with
the Scheffe method. Influence of preoperative dyspar-
eunia and, impact of the impossibility to explore the
right ovarian vein on the final clinical score, were
studied by variance analysis using GLM SASEur J Vasc Endovasc Surg Vol 34, July 2007procedure completed by Scheffe method when the
global test was significant.
The comparison of clinical results with the type of
recurrences was performed by one factor analysis of
variance. Due to the small number of patients in
each group concerning varicose veins type 1 and 2
and similarly type 3 and 4 were gathered respectively
into 2 types ‘‘good’’ or ‘‘bad’’ results. Statistical signif-
icance was accepted for a P value of less than 0.05.
Results
The mean age of patients was 41.5 years (range 31e50).
The mean number of pregnancies was 2.5 per patient
(range 1e4). When a patient had previously under-
gone surgery on one side only, embolisation was
performed on the corresponding side. Haemorrhoidal
pathology was found in 63% of the cases, and volumi-
nous vulvar varicose veins were present at delivery
in 47% of the cases. For only 3 patients with history
of deep venous thrombosis, embolisation was per-
formed on the same side. Only 2 patients were of
CEAP clinic class C3; the remaining 22 were CEAP
class C1 or C2. Of the 24 patients, 10 had been previ-
ously undergone surgical treatment for varicose veins,
with 3 left, 1 right, 4 bilateral great saphenous vein
stripping procedures and 2 perforator ligations at
the buttocks; 3 other patients had been operated on
twice previously and had been treated by phlebec-
tomy alone. The distribution of varicose veins is re-
ported on the Table 1. The number of phlebectomy
incisions related to the number of varicose veins
was 34 for the left limb (range 10e90) and 32 for the
right limb (range 12e65).
Results of embolisation
Pelvic venous angiography was performed by right
femoral access for 20 cases, left femoral access for
3 cases, and bilaterally for 1 case. All patients selected
Table 1. Distribution of varicose veins in the group of 24 female
patients presenting with pelvic venous incompetence. No
sapheno-femoral junction were incompetent. Several types of
varicose veins could be associated in a given patient
Type of varices N¼ 24
Perineal veins 24
Bilateral perineal veins 11
Right perineal veins 5
Left perineal veins 8
Vein of the sciatic nerve or fibular nerve 2
Perineal veinsþ great saphenous trunk 9
Recurrence after GSV stripping 10
Thigh or buttock perforators 2
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found to have radiologically demonstrated PVI. The
distribution of the embolised pelvic veins is reported
in the Table 2. In one case sciatic venous reflux was
fed by both internal iliac veins (left and right). All
these incompetent veins were successfully embolised.
Attempts at selective catheterisation failed in 14
cases for the right ovarian vein, in one case for the
left internal iliac vein, and in one case for the right in-
ternal iliac vein. During radiological investigation, the
absence of flow to the right side of the vena cava sug-
gested a competent right ovarian vein of small calibre.
On average, the number of used coils was 7.3 per
ovarian vein (range 3e11) and 5.6 per internal iliac
vein (range 3e9).
The only immediate complication was the migra-
tion of a 3 mm coil, just after deployment in a branch
of the left internal iliac vein; it migrated into the lower
lobar branch of the left pulmonary artery with no clin-
ical consequences.
Symptoms
All patients were re-evaluated at 45-days, 1, 2 and
3 years, except for 2 patients who were lost from the
3-year follow-up. Two other patients were unable to
come for the 3-year follow-up and but were inter-
viewed by telephone.
At 45-days, pain assessed by VAS showed a signifi-
cant amelioration in symptoms. Pelvic pain was eval-
uated at a mean score of 1 (range 0e4), dyspareunia at
0.3 (range 0e4) and pain on the former perineal or
buttock veins were at a mean score of 1.7 (range 0e7).
The difference was statistically significant between
each preoperative and postoperative sign (P<.001).
(Fig. 1.). No difference appears in the follow-up of
each postoperative clinical sign at 45 days, 1, 2 and
3 years.
After-45 days, the clinical score had decreased from
15.3 to 3.1, with maintenance of the improvement at
the 3 years follow-up.
At 2-year follow-up, 67% of patients had improved
symptoms by more than 80%.
Table 2. Number of embolisations of corresponding incompetent
pelvic veins
Type of incompetent pelvic vein Number of cases
Left ovarian vein 11
Left ovarian veinþ left internal iliac vein 5
Left ovarian veinþ right internal iliac vein 2
Right internal iliac vein 3
Left internal iliac vein 2
Left and right internal iliac vein 1Only one patient showed no improvement, and
had a previous score of 6 before embolization.
At 3-year follow-up, 68% of patients had improved
symptoms by more than 80%.
Improvement of the global symptom score was
respectively 77%, 80% and 76% at one, 2- and 3-year
follow-up. One patient (with only a 31% clinical im-
provement) was considered a failure as she presented
with a painful pelvic recurrence four months after
embolisation (Fig. 2). This patient had successfully
undergone left ovarian vein embolisation but it had
not been possible to explore her right ovarian vein.
One year later, angiography showed that the left
ovarian vein was totally obstructed; no pelvic venous
incompetence could be detected in the veins that
could be studied, but the right ovarian vein still could
not be demonstrated. Among the 9 patients who had
no symptoms at the 3-year follow-up, 4 no longer had
menstruation (menopausal patient or hormonal intra-
uterine device). In our study, we did not find any cor-
relation between a low clinical score and our inability
to investigate the right ovarian vein.
Varicose veins
Among the 22 patients re-evaluated 3-years following
treatment, only 10 presented with a type 1 recurrence
(no varices). Among the patients who presented with
new varices, 7 presented with a type 2, 3 a type 3, and
2 a type 4 recurrence (bad results). Two patients pre-
sented with other varices in another part of the limb
(small saphenous vein or great saphenous vein). Four
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Fig. 1. Evolution of pelvic pain, venous pain and dyspareu-
nia as assessed by VAS. The bar graph shows the mean
scores for each symptom at the five observation points.
The possible range of scores was 0 (no pain) e 10 (most
severe pain).Eur J Vasc Endovasc Surg Vol 34, July 2007
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at 3-year follow-up answered the questionnaire. One
had a clinical result type 1 and the other a type 4.
Due to the small number of patients in the 4 types
of results no significant difference can be demon-
strated concerning the final clinical score. After gath-
ering these 4 groups into only 2 groups: good
results (type 1þ 2) bad results (type 3þ 4) a significant
association was demonstrated between the patients
with a poor symptom score and varicose vein recur-
rence (bad results) (P< .001).
Dyspareunia
Dyspareunia noted at the preoperative evaluation was
not significantly associated with poor clinical results
(P< .079). The slight increase of the score at 3-year
follow-up was partly due to the small increase of
the level of dyspareunia.
Discussion
The outcome in our series of patients shows that
embolisation as treatment for PVI gives satisfactory
clinical results at 3-years follow-up. We used pelvic
vein angiography for our diagnostic technique which
was combined with treatment of affected veins. Others
have used duplex ultrasound investigation, but this is
controversial. Ovarian vein duplex scanning has been
unsuccessfully attempted in some series.8 For others
this provides an adequate evaluation in a large per-
centage of cases.9e12 One authors reports that PVI
can be easily detected by putting a CW Doppler probe
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Fig. 2. Evolution of clinical scores for each patient prior to
embolisation and up to 3-years follow-up. The vertical axis
shows the global symptom score, obtained by summing
each of the three symptoms scores at each time point. A
maximum value of 30 is possible. One patient with only
a 31% symptom improvement was considered to be a treat-
ment failure.Eur J Vasc Endovasc Surg Vol 34, July 2007on vulval varicose veins and on ‘‘point P’’ and ‘‘point
I’’.13 Duplex ultrasonography remains essential to
eliminate a ‘‘nutcracker syndrome’’.14
In our study, 14 right ovarian veins (58%) could not
be catheterised. It seems difficult to catheterise the
right ovarian vein from femoral vein access, which
is why Leal Monedero15 advises the use of the bra-
chial vein to access the upper vena cava (only 18%
of right ovarian vein catheterisations were not suc-
cessful). With a left femoral vein puncture, Maleux16
reports only 2% of right ovarian vein catheterisation
failures. Some authors advise a double right and left
femoral access with ovarian and internal iliac investi-
gation carried out as two stages, and others17 prefer
the transbrachial approach.
Complications of embolisation reported in medical
literature are rare. Accidental embolisation of glue
fragments,16 perforations of the ovarian vein with ex-
travasation of contrast, transient cardiac arrhythmia,
and coil embolism8 have been described, particularly
from the internal iliac vein level.18 Our results com-
pare with those of other series. Unfortunately, there
are very few published studies with results at three
years follow-up (Table 3).
Patient follow-up beyond a few years is difficult
to carry out, since pelvic pain is often an intricate
pathology. Changes in oral contraceptive treatment,
intra-uterine hormone-liberating devices, or pre-
menopausal hormonal substitution can lessen or
even eliminate a painful relapse. Moreover, symptoms
tend to decrease spontaneously with the passage of
time without any treatment. On the other hand, a new
pregnancy can generate a painful relapse. The results
concerning varicose vein recurrences are also difficult
to evaluate. Even if there appears to be a correlation
Table 3. Long-term results in different series according to the % of
patients experiencing improvement and % of clinical improve-
ment at follow-up. ND[ no data
N % of
patients
with
improvement
% of
clinical
improvement
Follow-up
months
Creton
[current study]
2006 24 50 100 36
Pieri19 2003 33 61 100 9
Garret17 2002 13 ND ND 18
Maleux16 2000 41 58.5 100 19.9
Venbrux18 2000 56 65 100 12
Cordt8 1998 11 40 100 13.4
Cotroneo20 1998 22 60 100 3
Eclavea21 1998 14 80 ND 12
Machan22 1998 23 78 ND 15
Tazarof23 1997 6 100 100 24
Capasso9 1997 19 58 100 15.4
Sichau24 1993 3 ND ND 18
117Embolisation for Pelvic Venous Incompetence in Womenbetween symptom recurrence and varicose vein recur-
rence it is difficult to claim that embolisation can pre-
vent varicose vein recurrence. At present, no studies
have been able to clarify this. This may in part explain
why indications for embolisation are more question-
able in post-menopausal women, who usually have
few symptomswhich could be improved by treatment.
Inpre-menopausalwomen, non-saphenousvaricose
veins of the upper thigh associated with symptoms of
PVI suggest that the pelvic veins shouldbe investigated
as apossible source of symptoms.Ovarianveins and in-
ternal iliac vein tributaries are often simultaneously in-
competent, justifying multiple embolisation to address
all possible sources of varices and symptoms.
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